Lumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth Hormone Deficiency
Virtual KOL Event is scheduled for Tuesday, April 27th @ 10:30 AM ETAUSTIN, Texas, April 14, 2021 (GLOBE NEWSWIRE) —…
Pharmaceuticals, Biotechnology and Life Sciences
Virtual KOL Event is scheduled for Tuesday, April 27th @ 10:30 AM ETAUSTIN, Texas, April 14, 2021 (GLOBE NEWSWIRE) —…
SOUTH SAN FRANCISCO, Calif., April 14, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage, oncology-focused biopharmaceutical company pioneering…
NASHVILLE, Tenn., April 14, 2021 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced it…
VANCOUVER, British Columbia, April 14, 2021 (GLOBE NEWSWIRE) — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV)…
NASHVILLE, Tenn., April 14, 2021 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced certain…
Core One Labs Looking to Compete in Psylocibin with a Proprietary Offering at a Fraction of Current Market CostAn Emerging…
Sky Premium Life King Eros and Queen Venus Supplements Sky Premium Life King Eros and Queen Venus Supplements King Eros…
Alimera grants exclusive license to Ocumension for a $10 million upfront payment and up to $89 million in additional sales-based…
TORONTO and HOUSTON, April 14, 2021 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA),…